// App-Quantinova.ai

: A phase II trial of pembrolizumab combined with platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial.

Researchers

Presenter

  • Fernando Cotait Maluf

Principal Investigators

  • Karine Trindade

  • Daniel D Almeida Preto

  • Murilo de Almeida Luz

  • Patricia Milhomem Beato

  • Diogo Assed Bastos

  • Anamaria Aranha Camargo

  • Cristina Beatriz Cazabuena Bonorino

  • Rafaela Gomes de Jesus

  • Fernando Monteiro

  • Joao Paulo Holanda Soares

  • Eduardo Eduardo Werneck De Carvalho

  • Victor Marcondes Lopes dos Santos

  • Gustavo Werutsky

  • Taiane Francieli Rebelatto

  • Andre P. Fay

Medical Centers

  • Hospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil and Hospital Israelita Albert Einstein, São Paulo, Brazil

  • Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil and PUCRS School of Medicine, Porto Alegre, Brazil

  • H Cancer de Barretos, Barretos, Brazil

  • Hospital Erasto Gaertner, Curitiba, Brazil

  • Latin American Cooperative Oncology Group, Porto Alegre, Brazil

  • Hospital Haroldo Juacaba, Instituto do Cancer do Ceara, Fortaleza, Brazil

  • Hospital Universitário – Universidade de Brasília, Brasília, Brazil

  • Instituto Nacional de Cancer - INCA, Rio De Janeiro, Brazil

  • Hospital Sirio Libanes, Sao Paulo, Brazil

  • Oncológica do Brasil, Belém, Brazil

  • Universidade Federal de Ciencias da Saude de Porto Alegre, Porto Alegre, Brazil

  • Fundação Amaral Carvalho, Jaú, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Penile carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Carboplatin

  • Cisplatin

  • Adrucil injection

Outcome

  • N/A

Study Design

  • Single Arm

  • Multicenteric

Phase

  • II

Study Id's

  • NCT04224740

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved